Revelation Biosciences (REVB) Total Non-Current Liabilities (2020 - 2025)
Revelation Biosciences (REVB) recorded Total Non-Current Liabilities of $1.85 million in Q3 2025, down 54.3% from $4.06 million a year earlier but up 18.2% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
At the end of FY2024, Revelation Biosciences reported Total Non-Current Liabilities of $1.91 million, down 64.8% from FY2023.
- Annual Total Non-Current Liabilities has a four-year compound annual growth rate of -59.2% (FY2020 to FY2024).
- Across earlier years, Total Non-Current Liabilities came in at $5.42 million in FY2023, $1.13 million in FY2021 (-98.4%) and $69.26 million in FY2020.
- Quarterly Total Non-Current Liabilities has ranged from $1.09 million in Q1 2025 to $69.26 million in Q4 2020 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities has declined for five consecutive quarters, with an average decline of 19.3% over the last seven quarters.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 157.2% in Q2 2024, against a decline of 98.4% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.57 million (Q2 2025), $1.09 million (Q1 2025) and $1.91 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Revelation Biosciences | 3.17 Mn | -45.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 4.06 Mn |
| Jun 30, 2024 | 11.12 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 4.32 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 69.26 Mn |
API Access
Revelation Biosciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();